Email ID
Password
Scrip   
Par Pharma launches generic Ultram ER in US
20 November 2009
Nancy Faigen

Par Pharmaceutical has gained final US FDA approval of its extended-release tramadol product in 100mg and 200mg strengths, a generic version of Ortho-McNeil's ( Johnson & Johnson) once-daily Ultram ER. Following the approval on November 13th, Par immediately began shipping the analgesic,...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36